Acute adverse reactions attributed to allopurinol in hospitalised patients.
AUTOR(ES)
McInnes, G T
RESUMO
Of 29 524 hospitalised medical patients monitored in a drug surveillance programme 1835 (6.2%) received the xanthine oxidase inhibitor allopurinol. After the exclusion of skin reactions adverse effects were attributed to this drug in 33 (1.8%) patients, the most frequent being haematological abnormalities (11 patients, 0.6%) and diarrhoea and drug fever (5 each, 0.3%). Adverse effects were dose-related. Reactions were unrelated to age, weight, reason for therapy, admission blood urea, or albumin concentrations. Acute exacerbation of gout was troublesome in 3 patients (1 in 600 exposed).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1000756Documentos Relacionados
- Fatal pulmonary embolism in hospitalised medical patients.
- Adverse reactions to drugs in children.
- HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
- Reactions to alteplase in patients with acute thrombotic stroke
- Reactions to alteplase in patients with acute thrombotic stroke